Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Eli lilly and company crawled date : 2021 - 03 - 11 save search
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-03-11 (Crawled : 13:07) - fda.gov
PFE | News A | $26.26 1.0% -0.08% 36M
|
Health Technology
|
| O: 0.4%
H: 0.14%
C: -1.03%
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
|
| O: 0.52%
H: 0.36%
C: -0.63%
BMY | $49.14 0.43% 0.0% 7.9M
|
Health Technology
|
| O: 0.11%
H: 0.31%
C: -1.07%
ABBV | News | $167.89 0.89% 0.0% 5.6M
|
Health Technology
|
| O: 0.12%
H: 0.46%
C: -0.24%
SUPN | $29.71 1.05% 1.04% 350K
|
Health Technology
|
| O: 0.12%
H: 3.37%
C: 3.33%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: -0.31%
H: 0.63%
C: 0.08%
OTIC | $0.077
|
Health Technology
|
| O: 1.81%
H: 2.48%
C: 1.42%
OMER | $3.085 1.15% 1.13% 280K
|
Health Technology
|
| O: 2.46%
H: 1.25%
C: 0.36%
GILD | $66.95 0.29% 0.28% 5.6M
|
Health Technology
|
| O: -0.63%
H: 0.83%
C: -0.66%
BMRN | $89.52 1.0% 0.99% 1.2M
|
Health Technology
|
| O: 0.28%
H: 1.23%
C: -0.35%
BCRX | News | $4.41 -0.45% -0.45% 2.3M
|
Health Technology
|
| O: 1.62%
H: 0.65%
C: -6.07%
AMGN | News | $271.98 1.13% 1.12% 2.1M
|
Health Technology
|
| O: 0.3%
H: 1.43%
C: 0.22%
Rigel Announces Completion of Patient Enrollment for NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19 Patients
Published: 2021-03-11 (Crawled : 13:01) - biospace.com/
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
|
| O: 0.52%
H: 0.36%
C: -0.63%
RIGL | $1.12 3.7% 3.57% 3.3M
|
Health Technology
|
| O: 1.28%
H: 6.55%
C: 6.55%
covid phase 2 trial enroll
Dicerna to Host Webinar on DCR-AUD Alcohol Use Disorder Candidate on March 18, 2021
Published: 2021-03-11 (Crawled : 13:00) - biospace.com/
NVO | News | $125.26 2.08% 0.18% 3.6M
|
Health Technology
|
| O: 0.24%
H: 0.38%
C: -0.04%
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
|
| O: 0.52%
H: 0.36%
C: -0.63%
ALNY | $145.78 0.95% 0.94% 390K
|
Health Technology
|
| O: 2.62%
H: 3.97%
C: 3.45%
alcohol use disorder
Vir Biotechnology and GSK Announce VIR-7831 Reduces Hospitalization and Risk of Death in Early Treatment of Adults with COVID-19
Published: 2021-03-11 (Crawled : 02:00) - globenewswire.com
GSK | News | $40.59 2.11% -0.36% 3.8M
|
Health Technology
|
| O: -0.67%
H: 0.96%
C: 0.54%
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
|
| O: 0.52%
H: 0.36%
C: -0.63%
VIR | $8.11 2.01% 1.97% 1.1M
|
Health Technology
|
| O: 44.57%
H: 0.75%
C: -8.66%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: -0.31%
H: 0.63%
C: 0.08%
covid treatment risk biotech iot
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.